drugset / Trial / NCT02292290
Trial for People With Established Type 2 Diabetes During Ramadan
Phase 4
Completed
99 enrolled
University of Leicester
University Hospital Birmingham · collabUniversity Hospitals, Leicester · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Dual therapy with metformin and Liraglutide is more effective at helping people with established Type 2 Diabetes Mellitus (T2DM) observing Ramadan achieve a triple composite endpoint of weight reduction and/or maintenance and improved HaemaglobinA1c (HbA1c) and no severe hypoglycaemic events.
Timeline
- Start
- 2011-04
- Primary completion
- 2012-12
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Liraglutide | Peptide | 1.2 mg | — |
| Comparator | Pioglitazone | Small molecule | — | — |